Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


How the RPS helped make FMD 'fit for purpose in the UK'


I am disappointed to see that the National Pharmacy Association's role has not been recognised for it's efforts in making FMD 'fit for purpose'. This is not a matter of organisational ownership as we as a profession collectively want the right thing to be done for patients and practitioners, however, in the minefield of regulatory burden needing careful navigation that is FMD, the NPA has played a leading role. This has been through being the lead organisation within Pharmaceutical Group of the European Union (PGEU) for the UK for many years and importantly, this year with NPA Board member, Raj patel, as it's president.

Posted date

12 DEC 2017

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.